Related Experiment Video
Updated: Sep 28, 2025

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Dysfunction of S100A4+ effector memory CD8+ T cells aggravates asthma
Huilei Zhang1,2,3, Shuangqing Liu1,2,3, Yanan Li1
1Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
S100A4 protein causes dysfunction in CD8+ T cells, worsening asthma by impairing their protective memory response. This protein disrupts effector functions, particularly IFN-γ secretion, leading to increased cell survival and disease severity.
Area of Science:
- Immunology
- Cellular Biology
- Respiratory Medicine
Background:
- Progressive loss of effector functions in CD8+ T cells, specifically IFN-γ secretion, contributes to asthma exacerbation.
- The precise mechanisms underlying CD8+ T cell dysfunction in asthma remain incompletely understood.
Purpose of the Study:
- To investigate the role of S100A4 in driving CD8+ T cell dysfunction.
- To elucidate the molecular mechanisms by which S100A4 impacts CD8+ T cell memory responses and asthma progression.
Main Methods:
- Utilized an ovalbumin (OVA)-induced asthmatic murine model.
- Characterized CD8+ T cell subsets based on S100A4 expression.
- Analyzed mitochondrial metabolism and gene transcription in CD8+ T cells.
Main Results:
- Identified two CD8+ T cell subsets: S100A4+ cells showed impaired effector function and increased proliferation, while S100A4- cells were prone to apoptosis.
- S100A4 upregulates mitochondrial metabolism, decreasing acetyl-CoA levels.
- Reduced acetyl-CoA impairs effector gene transcription (e.g., IFN-γ), promoting cell survival and tolerance.
Conclusions:
- S100A4 drives CD8+ T cell dysfunction, compromising protective memory responses and worsening asthma.
- S100A4+ CD8+ T cells reprogram into dysfunctional phenotypes, contributing to asthma pathogenesis.
- Targeting S100A4 may offer a therapeutic strategy for managing asthma by restoring CD8+ T cell function.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications
Classification of Asthma

